NEW YORK (GenomeWeb News) – SynapDx announced this week that Kevin Hrusovsky has joined the firm's board of directors. He most recently served as president of life sciences and technology at PerkinElmer. Hrusovsky had been CEO of Caliper Life Sciences from 2003 to 2011, when the firm was purchased by PerkinElmer for more than $600 million. He left PerkinElmer earlier this year but agreed to serve as a consultant for up to one year. He also serves on the board of directors of 908 Devices.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.